Nod sought for P-3 booster trial | India News – Times of India

NEW DELHI: Hyderabad-based pharmaceutical company Biological E has sought permission from India’s drug regulator to conduct the phase-3 clinical trial for its Covid-19 vaccine Corbevax as a single booster dose for those who have been fully vaccinated with Covishield or Covaxin.
Currently, phase 2/3 clinical trials of Corbevax, an RBD protein sub-unit vaccine to be administered in adults, is underway.

Source link

You may also like...